THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Peter Johnson to Fentanyl

This is a "connection" page, showing publications Peter Johnson has written about Fentanyl.
Connection Strength

3.875
  1. "Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". Ann Pharmacother. 2022 03; 56(3):370-371.
    View in: PubMed
    Score: 0.742
  2. Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children. Pharmacotherapy. 2021 04; 41(4):359-369.
    View in: PubMed
    Score: 0.732
  3. Conversion From Continuous Infusion Fentanyl to Continuous Infusion Hydromorphone in the Pediatric Intensive Care Unit. Ann Pharmacother. 2021 12; 55(12):1439-1446.
    View in: PubMed
    Score: 0.728
  4. Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children. Pediatr Crit Care Med. 2019 12; 20(12):e556-e564.
    View in: PubMed
    Score: 0.665
  5. Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children. Am J Health Syst Pharm. 2017 Aug 01; 74(15):1174-1183.
    View in: PubMed
    Score: 0.560
  6. Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children. J Opioid Manag. 2010 Mar-Apr; 6(2):117-24.
    View in: PubMed
    Score: 0.338
  7. Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. Ann Pharmacother. 2014 Mar; 48(3):335-42.
    View in: PubMed
    Score: 0.110
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES